Henry Randall Griffith
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Henry Randall Griffith has a total of 52 co-authors. Here are the top co-authors by number of shared publications:
Jan A. Den Hollander
Departments of Cardiology , University of Alabama at Birmingham , Birmingham, AL, USA
8 shared publicationsDaniel C. Marson
Department of Neurology, University of Alabama at Birmingham, USA
7 shared publicationsJohn C. Brockington
Departments of Neurology , University of Alabama at Birmingham , Birmingham, AL, USA ; Alzheimer's Disease Research Center , University of Alabama at Birmingham , USA
6 shared publicationsLindy E. Harrell
Departments of Neurology , University of Alabama at Birmingham , Birmingham, AL, USA ; Alzheimer's Disease Research Center , University of Alabama at Birmingham , USA ; Birmingham Regional Veterans Affairs Medical Center , Birmingham, AL, USA
6 shared publicationsOzioma C. Okonkwo
From the Departments of *Neurology, †Psychology, and #Cardiology, and ‡Alzheimer's Disease Research Center, University of Alabama at Birmingham, Birmingham, Alabama; §Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; ∥Department of Neurology, School of Medicine, the Johns Hopkins University, Baltimore, Maryland; and **Birmingham Regional Veterans Affairs Medical Center, Birmingham, Alabama
4 shared publicationsRoy C. Martin
From the Departments of *Neurology, †Psychology, and #Cardiology, and ‡Alzheimer's Disease Research Center, University of Alabama at Birmingham, Birmingham, Alabama; §Department of Psychiatry, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts; ∥Department of Neurology, School of Medicine, the Johns Hopkins University, Baltimore, Maryland; and **Birmingham Regional Veterans Affairs Medical Center, Birmingham, Alabama
4 shared publications
Latest Publications
- Open Access
- 6 April 2010
- Published by Taylor & Francis in Aging, Neuropsychology, and Cognition
- Vol. 17 (4) , 492-504
Brain Metabolic Correlates of Decision Making in Amnestic Mild Cognitive Impairment
Persons with amnestic mild cognitive impairment (MCI) have subtle impairments in medical decision-making capacity (MDC). We examined the relationship between proton magnetic resonance spectroscopy (MRS) and MDC in MCI. Twenty-nine MCI patients and 42 controls underwent MRS to obtain ratios of N-acetylaspartate (NAA)/Creatine (Cr), Choline (Cho)/Cr, and myo-Inositol (mI)/Cr of the posterior cingulate. They also completed the Capacity to Consent to Treatment Instrument (CCTI), a vignette-based instrument measuring decisional standards of expressing choice, appreciating consequences of choice, providing rational reasons for choice, and understanding treatment choices. Patients showed abnormal MRS ratios of mI/Cr and Cho/Cr compared to controls, and impairments on the CCTI understanding and reasoning Standards. Performance on the reasoning standard of the CCTI was correlated with NAA/Cr (r = .46, p < .05). The relationship of NAA/Cr with decision-making suggests a role for posterior cortical neuronal functioning in performance of complex IADLs in MCI.
- 6 April 2010
- Published by Taylor & Francis in Aging, Neuropsychology, and Cognition
- Vol. 17 (4) , 492-504
Open AccessBrain Metabolic Correlates of Decision Making in Amnestic Mild Cognitive Impairment
Persons with amnestic mild cognitive impairment (MCI) have subtle impairments in medical decision-making capacity (MDC). We examined the relationship between proton magnetic resonance spectroscopy (MRS) and MDC in MCI. Twenty-nine MCI patients and 42 controls underwent MRS to obtain ratios of N-acetylaspartate (NAA)/Creatine (Cr), Choline (Cho)/Cr, and myo-Inositol (mI)/Cr of the posterior cingulate. They also completed the Capacity to Consent to Treatment Instrument (CCTI), a vignette-based instrument measuring decisional standards of expressing choice, appreciating consequences of choice, providing rational reasons for choice, and understanding treatment choices. Patients showed abnormal MRS ratios of mI/Cr and Cho/Cr compared to controls, and impairments on the CCTI understanding and reasoning Standards. Performance on the reasoning standard of the CCTI was correlated with NAA/Cr (r = .46, p < .05). The relationship of NAA/Cr with decision-making suggests a role for posterior cortical neuronal functioning in performance of complex IADLs in MCI.
- Open Access
- 27 January 2010
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 58 (2) , 265-274
Magnetic Resonance Imaging Volume of the Angular Gyri Predicts Financial Skill Deficits in People with Amnestic Mild Cognitive Impairment
OBJECTIVES: To better understand how brain atrophy in amnestic mild cognitive impairment (MCI) as measured using magnetic resonance imaging (MRI) volumetrics could affect instrumental activities of daily living (IADLs) such as financial abilities. DESIGN: Controlled, matched‐sample, cross‐sectional analysis regressing MRI volumetrics with financial performance measures. SETTING: University medical and research center. PARTICIPANTS: Thirty‐eight people with MCI and 28 older adult controls. MEASUREMENTS: MRI volumetric measurement of the hippocampi, angular gyri, precunei, and medial frontal lobes. Participants also completed neuropsychological tests and the Financial Capacity Instrument (FCI). RESULTS: Correlations were performed between FCI scores and MRI volumes in the group with MCI. People with MCI performed significantly below controls on the FCI and had significantly smaller hippocampi. Among people with MCI, performance on the FCI was moderately correlated with angular gyri and precunei volumes. Regression models demonstrated that angular gyrus volumes were predictive of FCI scores. Tests of mediation showed that measures of arithmetic and possibly attention partially mediated the relationship between angular gyrus volume and FCI score. CONCLUSION: Impaired financial abilities in amnestic MCI correspond with volume of the angular gyri as mediated by arithmetic knowledge. The findings suggest that early neuropathology within the lateral parietal region in MCI leads to a breakdown of cognitive abilities that affect everyday financial skills. The findings have implications for diagnosis and clinical care of people with MCI and AD.
- 27 January 2010
- Published by Wiley in Journal of the American Geriatrics Society
- Vol. 58 (2) , 265-274
Open AccessMagnetic Resonance Imaging Volume of the Angular Gyri Predicts Financial Skill Deficits in People with Amnestic Mild Cognitive Impairment
OBJECTIVES: To better understand how brain atrophy in amnestic mild cognitive impairment (MCI) as measured using magnetic resonance imaging (MRI) volumetrics could affect instrumental activities of daily living (IADLs) such as financial abilities. DESIGN: Controlled, matched‐sample, cross‐sectional analysis regressing MRI volumetrics with financial performance measures. SETTING: University medical and research center. PARTICIPANTS: Thirty‐eight people with MCI and 28 older adult controls. MEASUREMENTS: MRI volumetric measurement of the hippocampi, angular gyri, precunei, and medial frontal lobes. Participants also completed neuropsychological tests and the Financial Capacity Instrument (FCI). RESULTS: Correlations were performed between FCI scores and MRI volumes in the group with MCI. People with MCI performed significantly below controls on the FCI and had significantly smaller hippocampi. Among people with MCI, performance on the FCI was moderately correlated with angular gyri and precunei volumes. Regression models demonstrated that angular gyrus volumes were predictive of FCI scores. Tests of mediation showed that measures of arithmetic and possibly attention partially mediated the relationship between angular gyrus volume and FCI score. CONCLUSION: Impaired financial abilities in amnestic MCI correspond with volume of the angular gyri as mediated by arithmetic knowledge. The findings suggest that early neuropathology within the lateral parietal region in MCI leads to a breakdown of cognitive abilities that affect everyday financial skills. The findings have implications for diagnosis and clinical care of people with MCI and AD.
- 30 November 2009
- Published by Elsevier in Mathematics and Computers in Simulation
- Vol. 80 (3) , 561-571
An examination of Bayesian statistical approaches to modeling change in cognitive decline in an Alzheimer's disease population
- 30 November 2009
- Published by Elsevier in Mathematics and Computers in Simulation
- Vol. 80 (3) , 561-571
An examination of Bayesian statistical approaches to modeling change in cognitive decline in an Alzheimer's disease population
- Open Access
- 1 May 2009
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 24 (3) , 237-244
The Contribution of Executive Control on Verbal-Learning Impairment in Patients with Parkinson's Disease with Dementia and Alzheimer's Disease
Deficits in learning, memory, and executive functions are common cognitive sequelae of Parkinson's disease with dementia (PDD) and Alzheimer's disease (AD); however, the pattern of deficits within these populations is distinct. Hierarchical regression was used to investigate the contribution of two measures with executive function properties (Verbal Fluency and CLOX) on list-learning performance (CVLT-II total words learned) in a sample of 25 PDD patients and 25 matched AD patients. Executive measures were predictive of list learning in the PDD group after the contribution of overall cognition and contextual verbal learning was accounted for, whereas in the AD group the addition of executive measures did not add to prediction of variance in CVLT-II learning. These findings suggest that deficits in executive functions play a vital role in learning impairments in patients with PDD; however, for AD patients, learning difficulties appear relatively independent of executive dysfunction.
- 1 May 2009
- Published by Oxford University Press (OUP) in Archives of Clinical Neuropsychology
- Vol. 24 (3) , 237-244
Open AccessThe Contribution of Executive Control on Verbal-Learning Impairment in Patients with Parkinson's Disease with Dementia and Alzheimer's Disease
Deficits in learning, memory, and executive functions are common cognitive sequelae of Parkinson's disease with dementia (PDD) and Alzheimer's disease (AD); however, the pattern of deficits within these populations is distinct. Hierarchical regression was used to investigate the contribution of two measures with executive function properties (Verbal Fluency and CLOX) on list-learning performance (CVLT-II total words learned) in a sample of 25 PDD patients and 25 matched AD patients. Executive measures were predictive of list learning in the PDD group after the contribution of overall cognition and contextual verbal learning was accounted for, whereas in the AD group the addition of executive measures did not add to prediction of variance in CVLT-II learning. These findings suggest that deficits in executive functions play a vital role in learning impairments in patients with PDD; however, for AD patients, learning difficulties appear relatively independent of executive dysfunction.
- 1 February 2009
- Published by Elsevier in Brain and Cognition
- Vol. 69 (1) , 65-72
Contributions of volumetrics of the hippocampus and thalamus to verbal memory in temporal lobe epilepsy patients
- 1 February 2009
- Published by Elsevier in Brain and Cognition
- Vol. 69 (1) , 65-72
Contributions of volumetrics of the hippocampus and thalamus to verbal memory in temporal lobe epilepsy patients
- 1 November 2008
- Published by Wiley in Alzheimer's & Dementia
- Vol. 4 (6) , 421-427
Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia
Background: Few comparative studies exist of metabolic brain changes among neurodegenerative illnesses. We compared brain metabolic abnormalities in Alzheimer's disease (AD) and in Parkinson's disease with dementia (PDD) as measured by proton magnetic resonance spectroscopy (MRS).Methods: Twelve patients with idiopathic PDD, 22 patients with probable mild AD, and 61 healthy older controls underwent posterior cingulate MRS.Results: Patients with AD exhibited reduced N‐acetyl aspartate (NAA)/creatine (Cr) (P < .05) and increased choline (Cho)/Cr (P < .05) and myo‐inositol (mI)/Cr (P < .01) compared with controls. Patients with PDD exhibited reduced NAA/Cr (P < .05) and glutamate (Glu)/Cr (P < .01) compared with controls. There was reduced Glu/Cr in PDD compared with AD (P < .01).Conclusions: Patients with AD and patients with PDD exhibited distinct brain metabolic MRS profiles. Findings suggest that comparison of brain MRS profiles across dementias provides useful direction for future study.
- 1 November 2008
- Published by Wiley in Alzheimer's & Dementia
- Vol. 4 (6) , 421-427
Brain metabolism differs in Alzheimer's disease and Parkinson's disease dementia
Background: Few comparative studies exist of metabolic brain changes among neurodegenerative illnesses. We compared brain metabolic abnormalities in Alzheimer's disease (AD) and in Parkinson's disease with dementia (PDD) as measured by proton magnetic resonance spectroscopy (MRS).Methods: Twelve patients with idiopathic PDD, 22 patients with probable mild AD, and 61 healthy older controls underwent posterior cingulate MRS.Results: Patients with AD exhibited reduced N‐acetyl aspartate (NAA)/creatine (Cr) (P < .05) and increased choline (Cho)/Cr (P < .05) and myo‐inositol (mI)/Cr (P < .01) compared with controls. Patients with PDD exhibited reduced NAA/Cr (P < .05) and glutamate (Glu)/Cr (P < .01) compared with controls. There was reduced Glu/Cr in PDD compared with AD (P < .01).Conclusions: Patients with AD and patients with PDD exhibited distinct brain metabolic MRS profiles. Findings suggest that comparison of brain MRS profiles across dementias provides useful direction for future study.
- 1 August 2008
- Published by Elsevier in Epilepsy & Behavior
- Vol. 13 (2) , 376-380
The safety and tolerability of galantamine in patients with epilepsy and memory difficulties
- 1 August 2008
- Published by Elsevier in Epilepsy & Behavior
- Vol. 13 (2) , 376-380
The safety and tolerability of galantamine in patients with epilepsy and memory difficulties
- 1 January 2008
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 22 (1) , 54-60
Brain N-acetylaspartate is Reduced in Parkinson Disease With Dementia
Persons with Parkinson disease (PD) are at risk of developing dementia. Of the dementias affecting patients with PD, PD with dementia (PDD) is not well understood, although brain imaging studies to date have observed characteristic patterns of brain atrophy. Metabolic differences have been observed in magnetic resonance spectroscopy (MRS) studies comparing patients with PDD to nondemented PD patients, although it is unclear whether PDD patients have abnormally low MRS ratios compared with healthy age-matched adults. In this study, 12 patients with PDD, 12 patients with PD and no dementia, and 12 age-matched healthy older adults underwent MRS of the posterior cingulate gyrus. Patients with PDD showed lower N-acetylaspartate/creatine (NAA/Cr) compared with controls (P=0.004) and compared with nondemented PD patients (P=0.003). No abnormalities were observed in choline/Cr or myo-Inositol/Cr. NAA/Cr was correlated with mental status in patients with PD and in patients with PDD (r=0.56; P=0.029). The findings suggest that reduced NAA/Cr of the posterior cingulate could be used as a marker for dementia in patients with PD. Future studies investigating the utility of brain MRS as a predictor of dementia in PD and comparing brain metabolism in PDD with other dementias seem warranted.
- 1 January 2008
- Published by Wolters Kluwer Health in Alzheimer Disease & Associated Disorders
- Vol. 22 (1) , 54-60
Brain N-acetylaspartate is Reduced in Parkinson Disease With Dementia
Persons with Parkinson disease (PD) are at risk of developing dementia. Of the dementias affecting patients with PD, PD with dementia (PDD) is not well understood, although brain imaging studies to date have observed characteristic patterns of brain atrophy. Metabolic differences have been observed in magnetic resonance spectroscopy (MRS) studies comparing patients with PDD to nondemented PD patients, although it is unclear whether PDD patients have abnormally low MRS ratios compared with healthy age-matched adults. In this study, 12 patients with PDD, 12 patients with PD and no dementia, and 12 age-matched healthy older adults underwent MRS of the posterior cingulate gyrus. Patients with PDD showed lower N-acetylaspartate/creatine (NAA/Cr) compared with controls (P=0.004) and compared with nondemented PD patients (P=0.003). No abnormalities were observed in choline/Cr or myo-Inositol/Cr. NAA/Cr was correlated with mental status in patients with PD and in patients with PDD (r=0.56; P=0.029). The findings suggest that reduced NAA/Cr of the posterior cingulate could be used as a marker for dementia in patients with PD. Future studies investigating the utility of brain MRS as a predictor of dementia in PD and comparing brain metabolism in PDD with other dementias seem warranted.
- 1 October 2007
- Published by Wiley in NMR in Biomedicine
- Vol. 21 (4) , 381-387
Reduced brain glutamate in patients with Parkinson's disease
An understanding of the role played by glutamate (Glu) in idiopathic Parkinson's disease (PD) has remained somewhat elusive. Animal models of PD suggest that over‐activity of Glu receptors complicates the motor symptoms of PD and that Glu blockade may be a pharmacologic target in PD, whereas patient autopsy studies have proved less convincing for changes in Glu. No previous 1H MRS patient studies have documented changes in glutamate. All but one of these previous studies were performed at 1.5 T. We performed 3 T 1H MRS of the posterior cingulate gyrus in 12 non‐demented patients with PD and 12 age‐matched, neurologically normal control participants. Glu, N‐acetylaspartate (NAA) and choline‐containing compounds (Cho) measured in reference to creatine + phosphocreatine (Cr) were determined from single‐voxel proton MR spectra measured by PRESS at TE of 80 ms. The results show that the Glu/Cr ratio was reduced in patients with PD compared with controls (t = 2.54; P = 0.019), whereas no differences were observed in NAA/Cr or Cho/Cr ratios. These findings suggest that a reduction in Glu occurs in the cerebral cortex of patients with PD. 1H MRS at 3 T should be investigated in future studies as a means of tracking the course of metabolic brain changes in association with progression of disease in patients with PD. Copyright © 2007 John Wiley & Sons, Ltd.
- 1 October 2007
- Published by Wiley in NMR in Biomedicine
- Vol. 21 (4) , 381-387
Reduced brain glutamate in patients with Parkinson's disease
An understanding of the role played by glutamate (Glu) in idiopathic Parkinson's disease (PD) has remained somewhat elusive. Animal models of PD suggest that over‐activity of Glu receptors complicates the motor symptoms of PD and that Glu blockade may be a pharmacologic target in PD, whereas patient autopsy studies have proved less convincing for changes in Glu. No previous 1H MRS patient studies have documented changes in glutamate. All but one of these previous studies were performed at 1.5 T. We performed 3 T 1H MRS of the posterior cingulate gyrus in 12 non‐demented patients with PD and 12 age‐matched, neurologically normal control participants. Glu, N‐acetylaspartate (NAA) and choline‐containing compounds (Cho) measured in reference to creatine + phosphocreatine (Cr) were determined from single‐voxel proton MR spectra measured by PRESS at TE of 80 ms. The results show that the Glu/Cr ratio was reduced in patients with PD compared with controls (t = 2.54; P = 0.019), whereas no differences were observed in NAA/Cr or Cho/Cr ratios. These findings suggest that a reduction in Glu occurs in the cerebral cortex of patients with PD. 1H MRS at 3 T should be investigated in future studies as a means of tracking the course of metabolic brain changes in association with progression of disease in patients with PD. Copyright © 2007 John Wiley & Sons, Ltd.
- 6 August 2007
- Published by Taylor & Francis in Journal of Clinical and Experimental Neuropsychology
- Vol. 29 (6) , 599-609
Executive function is associated with brain proton magnetic resonance spectroscopy in amnestic mild cognitive impairment
Persons with amnestic mild cognitive impairment (MCI) show deficits on executive function measures, although the neuroanatomic basis of executive function in MCI is unknown. We investigated cognitive correlates of 3-tesla proton magnetic resonance spectroscopy (MRS) of the posterior cingulate gyrus in 26 MCI patients. Posterior cingulate ratio of myo-inositol to creatine (mI/Cr) was negatively correlated (−.51) with spontaneous clock drawing. This relationship was not attenuated after accounting for age, overall cognitive function, or memory performance. This finding suggests a role for the posterior cingulate in executive function in MCI. Proton MRS may offer a means to track neurometabolic changes associated with cognitive impairment in MCI.
- 6 August 2007
- Published by Taylor & Francis in Journal of Clinical and Experimental Neuropsychology
- Vol. 29 (6) , 599-609
Executive function is associated with brain proton magnetic resonance spectroscopy in amnestic mild cognitive impairment
Persons with amnestic mild cognitive impairment (MCI) show deficits on executive function measures, although the neuroanatomic basis of executive function in MCI is unknown. We investigated cognitive correlates of 3-tesla proton magnetic resonance spectroscopy (MRS) of the posterior cingulate gyrus in 26 MCI patients. Posterior cingulate ratio of myo-inositol to creatine (mI/Cr) was negatively correlated (−.51) with spontaneous clock drawing. This relationship was not attenuated after accounting for age, overall cognitive function, or memory performance. This finding suggests a role for the posterior cingulate in executive function in MCI. Proton MRS may offer a means to track neurometabolic changes associated with cognitive impairment in MCI.